Cell Source, Inc. (CLCS) income statement
CLCSOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q1 FY2025, quarter ended Mar 31, 2025Last filing: 10-Q on May 14, 2026
$0.49−0.00 (-0.01%)
Close on Oct 19, 2026Market cap $21.99MP/E –Yield –
Cell Source, Inc. financial ratios
See a number that looks wrong?